These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2174158)

  • 1. [Local thrombolytic treatment of deep vein thrombosis with small doses of plasminogen activator].
    Marçon JL; Bonijoly S; Favre E
    Presse Med; 1990 Oct; 19(35):1639. PubMed ID: 2174158
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of thrombolytic treatment in venous thrombosis. Experience with streptokinase-based regimens.
    Marbet GA; Duckert F
    Vasa; 1986; 15(4):359-64. PubMed ID: 3799023
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombolytic therapy in deep venous thrombosis. Initial clinical experience].
    Albuquerque LC; Silveira F; Zago AJ; Bettio J; Petracco JB
    Arq Bras Cardiol; 1997 Feb; 68(2):125-8. PubMed ID: 9433840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
    Juhan-Vague I; Stassen JM; Alessi MC; Elias A; Aillaud MF; Serradimigni A; Collen D
    Semin Thromb Hemost; 1989 Oct; 15(4):390-4. PubMed ID: 2554499
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of urokinase in pregnancy. Two success stories.
    La Valleur J; Molina E; Williams PP; Rolnick SJ
    Postgrad Med; 1996 May; 99(5):269-70, 272-3. PubMed ID: 8650092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of potentiation and rapid action in models of venous thrombosis in dogs upon combined administration of the plasminogen tissue activator and urokinase modified by fibrinogen].
    Maksimenko AV; Tishchenko EG; Petrova ML; Golubykh VL
    Biull Eksp Biol Med; 1996 Jan; 121(1):48-51. PubMed ID: 8680005
    [No Abstract]   [Full Text] [Related]  

  • 7. [In situ thrombolysis in the treatment of venous thrombosis of effort in the arm].
    Pegis JD; Papon X; Pasco A; Regnard O; Abraham P; Enon B
    J Mal Vasc; 1997 Jul; 22(3):187-92. PubMed ID: 9303935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.
    Faivre R; Neuhart E; Mirshahi M; Mirshahi M; Soria C; Soria J; Bassand JP; Caen JP; Maurat JP
    Semin Thromb Hemost; 1989 Oct; 15(4):435-9. PubMed ID: 2554504
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
    Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin for the treatment of deep vein thrombosis.
    Thompson-Ford JK
    Pharmacotherapy; 1998; 18(4):748-58. PubMed ID: 9692649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of deep vein thrombosis.
    Cina G; Marra R; Cotroneo AR; Crucitti F
    Rays; 1996; 21(3):397-416. PubMed ID: 9063058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin.
    Forbes CD
    Br J Clin Pract; 1989 Nov; 43(11):396-400. PubMed ID: 2558702
    [No Abstract]   [Full Text] [Related]  

  • 14. Catheter-directed thrombolysis in the treatment of phlegmasia cerulea dolens.
    Patel NH; Plorde JJ; Meissner M
    Ann Vasc Surg; 1998 Sep; 12(5):471-5. PubMed ID: 9732427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Actual state of thrombolytic treatment of recent vein thrombosis and pulmonary embolism (author's transl)].
    Verstraete M
    J Mal Vasc; 1981; 6(4):251-6. PubMed ID: 7198677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current and future use of thrombolytic therapy.
    Sherry S; Gustafson E
    Annu Rev Pharmacol Toxicol; 1985; 25():413-31. PubMed ID: 3890708
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring of therapy for deep vein thrombosis using magnetic resonance imaging.
    Francis CW; Foster TH; Totterman S; Brenner B; Marder VJ; Bryant RG
    Acta Radiol; 1989; 30(4):445-6. PubMed ID: 2775606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nursing care of patients with deep venous thrombosis of the lower extremities treated with rt-PA].
    Chen L; Lu J
    Zhonghua Hu Li Za Zhi; 1997 Aug; 32(8):448-9. PubMed ID: 9495963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolytic treatment of postoperative ischemia of the hand caused by thrombotic obstruction of the interdigital artery: a case].
    Salvatori FM; Lemos A; Grasso F; Rossi P
    Radiol Med; 1996 Sep; 92(3):328-31. PubMed ID: 8975331
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urokinase therapy of deep vein thrombosis].
    Hasler K; Magdalinski D
    MMW Munch Med Wochenschr; 1984 Feb; 126(5):122-4. PubMed ID: 6423980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.